aTyr Pharma Inc (NASDAQ:LIFE)
| 2.12 Delayed Data As of Mar 29 |  -0.04 / -1.85%Today’s Change | 1.82 Today|||52-Week Range 5.97 | -3.20% Year-to-Date |
Latest LIFE News | Press Releases
No recent news for aTyr Pharma Inc.
Today’s Trading
| Previous close | 2.16 |
| Today’s open | 2.30 |
| Day’s range | 2.09 - 2.30 |
| Volume | 30,850 |
| Average volume (3 months) | 228,237 |
| Market cap | $100.5M |
Data as of 3:59pm ET, 03/29/2023
Growth & Valuation
| Earnings growth (last year) | +9.85% |
| Earnings growth (this year) | +17.81% |
| Earnings growth (next 5 years) | +13.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | 5.99 |
| Price/Book | 0.78 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PBYIPuma Biotechnology I... | +0.10 | +4.07% |
| ---- | ||
| EYENEyenovia Inc | -0.05 | -1.55% |
| CLLSCellectis SA | -0.13 | -6.14% |
Data as of 3:59pm ET, 03/29/2023
Financials
| Next reporting date | May 15, 2023 |
| EPS forecast (this quarter) | -$0.32 |
| Annual revenue (last year) | $10.4M |
| Annual profit (last year) | -$45.3M |
| Net profit margin | -436.53% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
